# Physician-Led GLP-1 and Metabolic Care | CED Clinic

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/metabolic/
> **Published:** 2026-04-08T01:19:46-04:00 | **Last Modified / Clinically Audited:** 2026-11-03T13:05:30-04:00
> **Clinical Summary:** Physician-led GLP-1 and metabolic care with Dr. Benjamin Caplan. Unhurried virtual evaluations, personalized titration, and ongoing medical follow-up.

---

[Overview](/metabolic/)
 [How It Works](/metabolic/metabolic-how-it-works/)
 [Practical Steps](/metabolic/metabolic-practical-steps/)
 [Medications](/metabolic/metabolic-medications/)
 [Full Guide](/metabolic/metabolic-glp1-guide/)
 [FAQ](/metabolic/metabolic-faq/)
 [About](/metabolic/metabolic-about/)
 [Book](/metabolic/metabolic-book/)
 
 [Book a Consultation](/metabolic/metabolic-book/)
 
 

 
 
 
 
 
 CED Clinic Metabolic Care
 

# GLP-1 care from a physician who actually knows you

 

Nationwide telehealth with a board-certified family physician.
 Thoughtful, unhurried, built for people who want more than
 a prescription and a portal login.

 
 
 
 
 Direct Clinical Answer & Consensus
 
 

Physician-led GLP-1 care pairs prescription incretin therapies with continuous medical evaluation from a dedicated family physician. Rather than automated app dispensing, treatment integrates baseline laboratory screening, conservative micro-titration to minimize gastrointestinal adverse effects, and longitudinal set-point stabilization. Patients retain direct physician access throughout active weight loss and subsequent maintenance.

 
 
 **Care Model:** Dedicated Attending Physician
 **Available Agents:** Semaglutide, Tirzepatide, Oral
 **Coverage Scope:** Nationwide Telehealth
 **Clinical Director:** Dr. Benjamin Caplan, MD (ABFM)
 
 
 

 
 [Book a Consultation](/metabolic/metabolic-book/)
 [See How It Works](/metabolic/metabolic-how-it-works/)
 [View Care Timeline](/metabolic/metabolic-practical-steps/)
 
 
 
 
 
 
 
 

 
 
 
 
 
 **20+ years** in [family medicine](https://cedclinic.com/cannabis-use-in-dementia-care-families-know/)
 
 
 
 **350,000+** patients evaluated
 
 
 
 Board-certified, **Tufts MD**
 
 
 
 Published in the **New England Journal of Medicine**
 
 
 
 Available **nationwide**
 
 
 

 
 
 
 
 

## Where are you right now?

 

Choose the path that fits. You can always change direction after we talk.

 
 
 [Starting out
 New to GLP-1 care
 You are exploring whether this is right for you, or you are ready to start but want a thorough evaluation first.
 Book Intro Consultation](/metabolic/metabolic-book/)
 [Getting going
 Already started, need support
 You are in early treatment, adjusting dose, managing side effects, or trying to build a sustainable rhythm.
 Book Ramp-Up Check-In](/metabolic/metabolic-book/)
 [Long haul
 Experienced, want ongoing care
 You have found what works and want a steady, dependable provider for maintenance, monitoring, and refinement over time.
 Book Maintenance Visit](/metabolic/metabolic-book/)
 
 
 

**Want to understand the visit schedule?** Explore our [Practical Steps & 12-Month Care Timeline](/metabolic/metabolic-practical-steps/) for detailed visit milestones, device techniques, and daily routine guidance.

 
 
 

 
 
 
 
 
 

## Weight is a medical issue, not a willpower issue

 

Hunger signals, appetite regulation, insulin sensitivity, sleep, stress, genetics, hormones, and the medications you may already take all affect weight in ways that have nothing to do with effort or discipline.

 

If you have tried hard and still cannot lose weight, that is not a personal failure. It is a medical situation that deserves a real medical conversation.

 
 [See how the evaluation works](/metabolic/metabolic-how-it-works/)
 
 
 
 
 
 
 
 

 
 
 
 
 

## What makes care here different

 

Not every GLP-1 program is built the same way.

 
 
 
 01
 
 

### One physician, not a provider network

 

You see Dr. Caplan. Not a rotating pool of practitioners. Not an app-based nurse triage. The same board-certified physician, every visit, who knows your history.

 
 
 
 02
 
 

### Depth over speed

 

We do not prescribe in 5 minutes. We review your history, your current medications, your goals, and what matters to you personally. Thorough evaluation is not a barrier to care. It is the care.

 
 
 
 03
 
 

### Long-term thinking

 

GLP-1 treatment is not a short-term fix. We help you think through what sustainable treatment looks like, including maintenance, monitoring, and what happens when you eventually want to taper.

 
 
 
 04
 
 

### Honest about fit

 

If GLP-1 treatment is not right for you, we will tell you and explain why. A visit where the answer is “not yet” or “there is a better path” is still a useful visit.

 
 
 
 05
 
 

### All FDA-approved options

 

Semaglutide, tirzepatide, oral semaglutide, and other approved options are all on the table. We match treatment to the patient, not the other way around. [See the medication overview](/metabolic/metabolic-medications/)

 
 
 
 06
 
 

### Available nationwide

 

Virtual consultations available across most of the United States. No waiting room, no commute. The same quality of care regardless of where you live.

 
 
 
 
 

 
 
 
 

## What patients say

 
 
 

> “I had tried everything before. Dr. Caplan was the first physician who actually listened to my full history before talking about treatment. That made all the difference.”

 Patient, New England (Maintenance care)
 
 
 

> “I was nervous about side effects and kept putting it off. He walked me through everything patiently and we started slowly. A year later I am in a completely different place.”

 Patient, Southeast (Ramp-up care)
 
 
 

> “I had tried a telehealth prescription service before. It felt like a vending machine. This is an actual medical practice. There is a real difference.”

 Patient, Midwest (Intro consultation)
 
 
 
 

 
 
 
 
 

## Tell me your situation

 

Here is how we approach common starting points.

 
 
 
 I am not sure I want to do this
 We will take it at your pace. The first visit is about information, not commitment.
 
 
 I am worried about side effects
 We start low, go slow, and adjust based on how you actually feel, not a generic protocol.
 
 
 I have tried GLP-1s and had a bad experience
 That history matters. We will review what happened and decide together whether and how to try again.
 
 
 I want quick results
 We will move as efficiently as safety allows and be honest if your timeline expectations need adjusting.
 
 
 I have been doing well and just need maintenance
 We focus on keeping what is working, monitoring, and staying ahead of what comes next.
 
 
 I take other medications and I am concerned about interactions
 That is exactly the kind of evaluation that belongs in this conversation. We go through everything.
 
 
 
 

 
 
 
 
 

## Ready to start a real conversation about your health?

 

No pressure. No obligation to any specific outcome. Just a careful, unhurried evaluation from a physician who will actually take the time.

 
 [Book a Consultation](/metabolic/metabolic-book/)
 [Start with a Brief Intake](/metabolic/metabolic-book/#step-1-intake)

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
